Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Maryland, Baltimore, Maryland; and
Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Maryland, Baltimore, Maryland; and.
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2019-1097.
Polysomnography is central to the diagnosis and management of childhood obstructive sleep apnea (OSA). However, it is not known whether the treatment-related outcomes of OSA are causally associated with its resolution or changes in severity as determined by polysomnography.
Polysomnographic, cognitive, behavioral, quality-of life, and health outcomes at baseline and at 7 months were obtained from the Childhood Adenotonsillectomy Trial, a randomized trial comparing the outcomes of early adenotonsillectomy to watchful waiting in children with OSA. We used causal mediation analysis to measure the changes in 18 outcomes independently attributable to polysomnographic resolution or changes in severity after adjusting for confounding variables.
A total of 398 children aged 5 to 9 years were included. A total of 244 (61%) experienced resolution of OSA at follow-up. Polysomnographic resolution of the condition accounted for small but significant proportions of changes in symptoms (proportion mediated [95% confidence interval] 0.13 [0.07 to 0.21]; < .001) and disease-specific quality of life (0.11 [0.04 to 0.20]; = .004). Changes in polysomnographic severity similarly mediated symptom score (proportion mediated 0.18 [0.11 to 0.26]; < .001) and disease-specific quality-of-life outcomes (0.20 [0.10 to 0.31]; = .004). Importantly, significant mediation effects were not identified for any of the other 16 outcomes. No significant interactions were observed between the trial arms.
The majority of the treatment-related changes in outcomes of OSA in school-aged children are not causally attributable to polysomnographic resolution or changes in its severity. These results underscore the limited utility of polysomnographic thresholds in the management of childhood OSA.
多导睡眠图是儿童阻塞性睡眠呼吸暂停(OSA)诊断和治疗的核心。然而,目前尚不清楚 OSA 的治疗相关结果是否与多导睡眠图确定的 OSA 缓解或严重程度变化有因果关系。
从儿童腺样体扁桃体切除术试验中获得基线和 7 个月时的多导睡眠图、认知、行为、生活质量和健康结果,该试验是一项比较 OSA 儿童早期腺样体扁桃体切除术与观察等待的随机试验。我们使用因果中介分析来衡量在调整混杂变量后,多导睡眠图缓解或严重程度变化对 18 个结果的独立变化。
共纳入 398 名 5 至 9 岁的儿童。共有 244 名(61%)在随访时 OSA 得到缓解。该疾病的多导睡眠图缓解占症状变化的小但有统计学意义的比例(中介比例[95%置信区间]0.13[0.07 至 0.21];<0.001)和疾病特异性生活质量(0.11[0.04 至 0.20];=0.004)。多导睡眠图严重程度的变化同样介导了症状评分(中介比例 0.18[0.11 至 0.26];<0.001)和疾病特异性生活质量结果(0.20[0.10 至 0.31];=0.004)。重要的是,在其他 16 个结果中没有发现显著的中介效应。试验组之间没有观察到显著的交互作用。
学龄儿童 OSA 治疗相关结果的大部分变化与多导睡眠图缓解或严重程度变化没有因果关系。这些结果强调了多导睡眠图阈值在儿童 OSA 管理中的有限效用。